Powered by OpenAIRE graph
Found an issue? Give us feedback
image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/ I.R. "OLYMPIAS"arrow_drop_down
image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/
I.R. "OLYMPIAS"
Article . 2003
Data sources: I.R. "OLYMPIAS"
versions View all 2 versions
addClaim

HIV: opportunistic infections.

Authors: Ioannidis, J.; Wilkinson, D.;

HIV: opportunistic infections.

Abstract

Clin Evid

Country
Greece
Related Organizations
Keywords

Anti-HIV Agents, Antitubercular Agents/therapeutic use, Anti-Infective Agents/therapeutic use, Antitubercular Agents, Acyclovir, Azithromycin, Valine/*analogs & derivatives/therapeutic use, Antiviral Agents, Azithromycin/therapeutic use, Pneumonia, Pneumocystis/drug therapy/prevention & control, Chickenpox, Anti-Infective Agents, Clarithromycin, AIDS-Related Opportunistic Infections/drug therapy/*prevention & control, Herpes Simplex/drug therapy/prevention & control, Humans, Chickenpox/drug therapy/prevention & control, Anti-HIV Agents/administration & dosage/therapeutic use, Ganciclovir, Clarithromycin/therapeutic use, Atovaquone, Mycobacterium avium-intracellulare Infection, Antiviral Agents/therapeutic use, AIDS-Related Opportunistic Infections, Pneumonia, Pneumocystis, Toxoplasmosis/drug therapy/prevention & control, Herpes Simplex, Tuberculosis, Pulmonary/drug therapy/prevention & control, Mycobacterium avium-intracellulare Infection/drug therapy/prevention & control, Rifabutin, Ganciclovir/therapeutic use, Cytomegalovirus Infections, Cytomegalovirus Infections/drug therapy/prevention & control, Drug Therapy, Combination, Acyclovir/*analogs & derivatives/therapeutic use, Trimethoprim-Sulfamethoxazole Combination/therapeutic use, Rifabutin/therapeutic use, Naphthoquinones/therapeutic use, Toxoplasmosis, Naphthoquinones

  • BIP!
    Impact byBIP!
    selected citations
    These citations are derived from selected sources.
    This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
    0
    popularity
    This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.
    Average
    influence
    This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
    Average
    impulse
    This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.
    Average
Powered by OpenAIRE graph
Found an issue? Give us feedback
selected citations
These citations are derived from selected sources.
This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
BIP!Citations provided by BIP!
popularity
This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.
BIP!Popularity provided by BIP!
influence
This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
BIP!Influence provided by BIP!
impulse
This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.
BIP!Impulse provided by BIP!
0
Average
Average
Average
Green